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Abstract
To examine the usefulness of protein disorder predictions as a tool for the comparative analysis of
viral proteins, a relational database has been constructed. The database includes proteins from
influenza A and HIV-related viruses. Annotations include viral protein sequence, disorder
prediction, structure, and function. Location of each protein within a virion, if known, is also
denoted. Our analysis reveals a clear relationship between proximity to the RNA core and the
percentage of predicted disordered residues for a set of influenza A virus proteins.
Neuraminidases (NA) and hemagglutinin (HA) of major influenza A pandemics tend to pair in such
a way that both proteins tend to be either ordered-ordered or disordered-disordered by
prediction. This may be the result of these proteins evolving from being lipid-associated. High
abundance of intrinsic disorder in envelope and matrix proteins from HIV-related viruses likely
represents a mechanism where HIV virions can escape immune response despite the availability of
antibodies for the HIV-related proteins. This exercise provides an example showing how the
combined use of intrinsic disorder predictions and relational databases provides an improved
understanding of the functional and structural behaviour of viral proteins.
Background
Goals and objectives
Structures and functions of a large number of viral pro-
teins are not yet totally understood [1-5]. This may
account for the continuous need for the development of
novel computational and experimental tools suitable for
the viral protein analysis. Although experimental tech-
niques remain the major providers of structural and func-
tional knowledge, often, the experiments are expensive or
difficult to the point of infeasibility. The use of various
bioinformatics tools to predict structure and function rep-
resents an alternative approach that is gaining significant
attention. Comparative computational studies have
opened a new way for easier benchmarking and func-
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tional analysis of proteins. Here we examine the useful-
ness of intrinsic disorder predictions for studying the viral
proteins. To this end, a set of biocomputing tools that
include relational database design and utilization of dis-
order prediction algorithms was elaborated.
Viral protein functions by proteins, location and virus type
Two families of RNA viruses, the Lentivirinae (HIV) and
the Orthomyxoviridae (Influenza), were used in this com-
parative study. These viral families were selected because
they are widely studied due to their involvement in major
outbreaks during the last century [5,6]. The Lentiviruses
include the HIV and the SIV viruses among others [7],
whereas the orthomyxoviruses encompass mainly the var-
ious influenza viruses [8].
The influenza A virion (which is a complete virus particle
with its RNA core and protein coat) is a globular particle
sheathed in a lipid bilayer derived from the plasma mem-
brane of its host (Figure 1A). Two integral membrane pro-
teins, hemagglutinin (HA) and neuraminidase (NA), are
studded in the lipid bilayer. Beneath the envelope, the
matrix formed by matrix proteins M1 and M2 is located.
This matrix encompasses eight pieces of the genomic
RNA, each in association with many copies of a nucleo-
protein (NP), some "non-structural" proteins with vari-
ous functions (e.g., NS1 and NS2) and several molecules
of the three subunits of its RNA polymerase. Sixteen HA
subtypes (or serotypes) and nine NA subtypes of influ-
enza A virus have been identified in different virus isola-
tions so far.
HIV is also an enveloped virus. Figure 1B represents a
model of its virion. The surface of the HIV virion is the
viral envelope made of the cellular membrane, which is
acquired when the virus leaves the host cell. Protruding
from the envelope is the viral glycoprotein, gp160, which
is made up of two component parts, the structural unit
(SU), gp120, and the transmembrane (TM), gp41. These
two surface proteins play important roles in attachment
and penetration of HIV into target cells. Inside the lipid
envelope, there is a matrix formed by Gag protein p17,
which holds the RNA-containing core in place. This cylin-
drical core is a proteinaceous capsid made of p24 protein.
The capsid contains two copies of the single-stranded
RNA genome and three key enzymes: protease, PR (p11);
integrase, IN (p32); and reverse transcriptase RT (p66), as
well as some other proteins.
Table 1 represents a list of some of the most important
proteins analyzed in this study. These proteins are
arranged by their approximate location in the HIV and
Influenza A virions [7-10]; i.e., according to their proxim-
ity to the core where the RNA is housed. The proteins that
are located closer to the core are likelier to be involved in
interaction with the viral RNA. Note: the exact locations of
some of the proteins within the virions are not known as
of yet.
Table 1 shows that proteins similarly located within the
virions of different viral types possess significant func-
tional similarities [11]. For example, similar functions can
be seen in the surface proteins (gp120, HA, NA) in both
influenza A and HIV viruses. Although Table 1 lists major
functions for several proteins, it is important to remember
that some of the functions are not totally understood or
are not known at all [1]. Multi-functionality of a protein
is, of course, also possible.
Intrinsic disorder
Many proteins are intrinsically disordered; i.e., they lack
rigid 3-D structure under physiological conditions in vitro,
Model structures of the influenza A (A) and HIV-1 (B) virions Figure 1






















gp41 BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
Page 3 of 14
(page number not for citation purposes)
existing instead as dynamic ensembles of interconverting
structures. Intrinsically disordered proteins [12] are also
known by several other names including "intrinsically
unstructured" [13] and "natively unfolded." [14-16]
While the function of a given protein is often determined
by its unique structure, comparative studies on several
exceptions to the structure-to-function mechanism led to
the realizations that intrinsically disordered proteins
share many sequence characteristics and so comprise a
distinct cohort. These intrinsically unstructured proteins
and regions differ from structured globular proteins and
domains with regard to many attributes, including amino
acid composition, sequence complexity, hydrophobicity,
charge, flexibility [12,15], and type and rate of amino acid
substitutions over evolutionary time [17]. Many of these
differences between ordered and intrinsically disordered
proteins were utilized to develop numerous disorder pre-
dictors. The disorder predictors used in this paper are
PONDR®s (Predictors of Naturally Disordered Regions)
VLXT and VL3 [18-21]. We utilized these predictors to
address the following question: Can disorder prediction
be used to determine or map at least some the functions
for viral proteins?
Results
Predicted intrinsic disorder in various viruses
Table 2 lists the average percentages of predicted disor-
dered residues (the percentage disorder rate) that have
been found in proteins studied by NMR or X-Ray crystal-
lography. They are also divided into PDB-Select 90 pro-
teins [22,23], lentivirus, and influenza A virus. Table 2
shows that the percentage of residues predicted to be dis-
ordered by PONDR® VLXT in proteins from a PDB-Select
90 set is 24 ± 2, whereas the corresponding value for
PONDR® VL3 predictions is 14 ± 2. Table 2 also shows that
predicted disorder is a bit more abundant in lentivirus
proteins in comparison with proteins from the influenza
virus. The values given in this table are the average per-
centages of disordered residues in a given dataset, not the
average percentages of disordered residues in each chain.
The former provides a better gauge of the mean since the
number of influenza and HIV-related proteins available in
PDB [22] is relatively small.
Averaged predicted disorder rates enable analysis of the 
viral protein disorder
Table 2 provides a simple measure to classify a given pro-
tein as ordered or disordered by prediction. For example,
Table 1: HIV and influenza viral proteins. Some of the most important HIV and influenza viral proteins are listed with a brief 
description of their functions. They are listed by the order of their location in the corresponding virions [7-10].
Major HIV proteins
Protein Function of the Protein Location
SU(gp120) Binding of host's CD4 to itself Virion Surface(SU)
TM (gp41) Involved in fusion with host Transmembrane (TM) at the Virion Envelope
MA (p17) Matrix Beneath the Enevelope
Vpua Virion release
Vpr Nucleus transportation of viral proteins Within capsid and beneath matrix
CA (p24) Main core protein Nucleocapsid
PR (p11) Protease. Within the Core
RT (p66) Reverse Transcriptase Within th Core
IN (p32) Integrase. Within the Core
Tata Transcription factor NAa
Major influenza A virus proteins
Protein Function/Description Location
HA Hemagglutinin allows the attachhment of host's CD4 to itself Envelope
NA Neuraminidase cleaves sialic acud group to allow virion release into the 
extracellular region.
Transmembrane (TM) at the Virion Envelope
MA (M1, M2) Protein assembly with membrane binding and disassociation Matrix: Beneath the Enevelope
NS1 Non-Structural Protein. Inhibits RNA splicing. RNA binding Within capsid and beneath matrix
NS2 Transportation of RNPb to cytoplasm
NP Nucleoprotein Nucleocapsid
PB1 Main core protein Binds to Nucleocapsid
a Positions of VPU and Tat in the virion is unclear
b Ribonucleoprotein (RNP)BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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the averaged predicted disorder rate for proteins from
PDBS90 is 24 ± 2 (15 ± 2). If this value is used as a bench-
mark for labelling a protein as moderately disordered or
mostly structured, then any protein that falls close to this
number with respect to percentage of predicted disor-
dered residues can safely be classified as 'moderately dis-
ordered' by prediction. The information in Table 2
provides the benchmarks for the analysis of the results
shown in Tables 3 and 4. Table 3 categorizes proteins
found in the HIV virus by their function and arranges data
by protein location in the virion. The envelope proteins
are placed on the forefront with gp120 being the Surface
Unit (SU). Just below the SU lies the gp41, which is a
transmembrane protein (TM). Using the information in
Table 2, we can tell that gp120 can be considered as quite
ordered by prediction, whereas the gp41 should be cate-
gorized as rather disordered. The amount of predicted
intrinsic disorder is high in matrix and capsid proteins, as
well as in Vpr and Tat proteins. Nef protein and integrase
are predicted to be moderately disordered, whereas both
protease and reverse transcriptase contain the least
amount of predicted disorder.
Table 4 gives the data on the abundance of disorder in
influenza A virus proteins. These data provide compari-
sons of proteins from orthomyxovirus and lentivirus. The
envelope of the orthomyxovirus contains hemagglutinin
(HA) and neuraminidase (NA) protein. While the per-
centage predicted disorder rate for gp120 does not vary
much by strains, predicted intrinsic disorder in both HA
and NA vary significantly by subtype (see Table 5). The
M1 is a matrix protein, which provides a link between the
surface protein and the capsid. M1 is predicted to be mod-
erately disordered. Both non-structural proteins of the
influenza A viruses were predicted to be rather disordered.
Similarly, both nucleoprotein and main core protein were
predicted to contain significant percentage of disordered
residues.
Table 6 summarizes some trends in the distribution of
intrinsic disorder among various functional classes of pro-
teins derived from the analysis of literature. First, a collec-
tion of RNA-binding proteins show a strong tendency to
be highly disordered, both experimentally and computa-
tionally. The next sets of proteins that have also been
observed disordered, though not as highly disordered as
Table 3: Summary of the predicted disorder rates in HIV proteins.
Protein Accession numbers %VLXT(VL3)a Methodsb Virus Type
SU 2i60.pdb, Subunit G 11 (0) X-Ray HIV-1
(gp120)
TM 2cmr.pdb, Subunit: S 34 (27) X-Ray HIV-1
(gp41) TM 1jek.pdb, Subunit: A 64 (0) X-Ray Visna
MA (p17) 1hiw.pdb, Subunit: A 61 (48) X-Ray HIV-1
VPR 1ceu.pdb, Subunit: A 39 (63) NMR HIV-1
VPUc 2goh.pdb, Subunit: A 26 (NA)d NMR HIV-1
CA (p24) 1afv.pdb, Subunit:A 48 (0) X-Ray HIV-1
PR (p11)e 1tcw.pdb, Subunit A 18 (0) X-Ray SIV
RT (p66)e 2hnz.pdb, Sunbunt: A 18 (10) X-Ray HIV-1
IN (p32)e 1k6y.pdb, Subunit: A 26 (7) X-Ray HIV-1
Nefc 1avz.pdb, Subunit: A 26 (31) X-Ray HIV-1
Tatc 1jfw.pdb, Subunit: A 100 (100) NMR HIV-1
aPercentage of residues in a chain that are predicted to be disordered.
bMethods used to characterize the proteins
cLocations of these proteins in virions have yet been determined. VPU is however, placed alongside with VPR for comparative purposes only.
dChain available is too short for VL3 analysis.
eExact locations of these proteins have yet been determined.
Table 2: Abundance of intrinsic disorder in various datasets.
Protein % Predicted Disordered X-raya % Predicted Disordered NMR % Predicted Disordered
PDBS90 24 ± 2 (14 ± 2) 34 ± 2 (32 ± 1) 24 ± 2 (15 ± 1)
HIV 27 ± 2 (16 ± 1) 50 ± 3 (41 ± 3) 34 ± 2 (19 ± 2)
Influenza 21 ± 2 (10 ± 2) 34 ± 3 (40 ± 3) 21 ± 2 (11 ± 2)
aPercentage of residues that are predicted to be disordered that have been characterized by X-ray crystallography.
Table presents means of predicted disorder by PONDR® VLXT. The corresponding PONDR® VL3 are shown in brackets. The total number of 
proteins used in this analysis was 34 for lentivirus, while the number of influenza A analyzed proteins is 27.BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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RNA-binding proteins, are DNA-binding proteins. Single-
span membrane proteins also contain significant intrinsic
disorder, except for the segment that crosses the mem-
brane, which is typically predicted to be ordered. Finally,
various enzymes as well as transmembrane proteins (e.g.
pores) are among the polypeptides with the least intrinsic
disorder. Overall, the results in this table are consistent
with previous studies on all of the SwissProt proteins,
which were partitioned by functional annotation [24-26].
Figure 2 presents data for the disorder distribution within
the major proteins from HIV and influenza viruses. The
proteins are labeled as "predicted to be ordered," "moder-
ately disordered," or "very disordered." The qualitative
values are assigned according to the PONDR® VLXT values
by comparison to the mean values of Table 2. Here, the
proteins whose percentages of predicted disordered resi-
dues are between 30–40% were considered as moderately
disordered. The proteins with the disorder scores above
40% and below 20% were considered as very disordered
or as ordered, respectively. Figure 2 shows that the
amount of predicted intrinsic disorder increases as the
protein becomes located closer to the viral core, which is
the site of the genomic RNA. In general, a comparison of
Tables 3, 4 and Figure 2 with the Table 6 indicates that
viral proteins follow the trend in the distribution of intrin-
sic disorder among functional classes previously
described for other proteins.
Discussion
Predicted disorder varies with protein type, protein 
location and function
Predicted disorder varies with location of protein in virion
There is an interesting correlation between the percentage
disorder rate and the protein localization within the vir-
ion. This phenomenon is especially clear for influenza
virus (see Figure 2), where the closer the protein gets to
the core, then higher the level of predicted disorder. This
can easily be explained by the increased likelihood of
colocalization of the RNA-binding proteins and the
genomic RNA in the viral core. This trend is also seen for
HIV proteins with the exception for the several enzymes,
which are located in the close proximity to the core (see
Figure 2). But of course enzymes need to be structured so
the active site can provide a catalytic surface, and so this
result is entirely consistent with previous work [24-26].
Hemagglutinin versus gp120
Data in Tables 3 – 4 and Figure 2 show that the surface
proteins are generally predicted to be ordered in both the
influenza and HIV viruses. HA is crucial in the entry of the
virus to the host. A cleavage at the disulfide bond between
subunits, HA1 and HA2, has to occur before the viral entry
can take place. The function of HA can be compared to
that of gp120, as gp120 is also known to play a crucial role
in mediating the entry of the virus into the host cell [1,27].
Neuraminidases, on the other hand, play enzymatic role
at the other end of the viral process. This protein cleaves
the sialic acid group from the oligosaccharide portion.
This cleavage step is needed for the virion to be released
into the extracellular region [28].
According to our analysis, gp120, like HA, is predicted to
be quite ordered. There are however, observed differences
in the prediction results for these two proteins: gp120 was
consistently predicted to be ordered, whereas the levels of
predicted order in influenza HA varied with the viral sub-
type. A summary of this can be found in Table 5. It is also
should be noted that both HA (HA2) and NA are trans-
membrane proteins [28,29].
Transmembrane proteins are more ordered
In HIV, a protein that spans the lipid membrane is the
transmembrane (TM) protein, gp41. This protein acts as a
fusion protein [30] and functions in membrane interac-
tions. This integral membrane protein contains a TM
anchor domain that holds this envelope protein in associ-
ation with the lipid bilayer [31]. This TM protein is
responsible for the fusion of the viral and cellular mem-
branes via its fusion peptide located in its extracellular, N-
terminal domain [32]. Previously transmembrane frag-
ments of channels and pores were predicted to be highly
ordered [24-26]. However, the situation might be quite
different for membrane proteins with relatively large
extra- and intracellular domains, e.g., for fusion proteins.
We now have an opportunity to analyse the predicted dis-
order rate of transmembrane proteins that are involved in
the membrane fusion. Table 3 shows that the predicted
disorder level for gp41 is quite sizeable (34% for PONDR®
VLXT). In fact, the amount of disorder in this protein is
significantly higher than that of the transmembrane pro-
teins (HA, NA) of the influenza A virus. This might be also
Table 4: Summary of the predicted disorder rates in influenza 
viral protein.
Protein Accessions %VLXT(VL3)a Method
HA1 (H1) 1ruz.pdb, Subunit H 12 (0) X-ray
HA2 (H1) 1ruz.pdb, Subunit:I 12 (0)
HA1 (H3) 1mqn.pdb, Subunit: 
A
25 (0) X-ray
HA2 (H3) 1mqn.pdb Subunit: B 19 (2)
NA (N1) 2hu0.pdb,/Sunit: S 8 (0) X-ray
M1 1ea3.pdb, Subunit: A 25 (0) X-ray
NS1 1xeq.pdb, Subunit: A 69 (63) X-ray
NS2 1pd3.pdb, Subunit: A 60 (23) X-ray
PB1 2hn8.pdb, Subunit: A 47 (NA) NMR
NP 2iqh.pdb, Subunit: A 44 (0) X-ray
aThe percentage of residues that are predicted ordered by VLXT. The 
parenthesized values are those in VL3.BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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correlated with the high level of predicted disorder in the
HIV matrix.
Similarly to gp41, HA is a transmembrane glycoprotein.
Both, gp41 and HA, are members of the class I viral fusion
proteins that mediate viral entry into cells. Class I viral
fusion proteins are thought to fold into a prefusion,
metastable conformation, which is then activated to
undergo a large conformational rearrangement to a lower
energy state, thereby providing the energy needed to
accomplish membrane fusion [33-35]. The role of HA as
a fusion protein and the associated large-scale conforma-
tional changes may help to account for the slightly higher
predicted disorder rates observed for HA in many sub-
types (see Table 5).
Analysis of the data in Table 3 revealed that transmem-
brane viral proteins are, in general, characterized by rela-
tively low predicted disorder rates. For instance, the Vpr
protein which is present in HIV but is not expressed in SIV
[36] and structure of which was determined by NMR is
predicted to be rather disordered (39% by PONDR® VLXT
and 64% by PONDR® VL3, Table 3). On the other hand,
Vpu was predicted to be more ordered (26% by PONDR®
VLXT) in agreement with the fact that this protein has a
transmembrane domain [37].
More disorder at the core
The matrix proteins, which form a layer below the lipid
envelope, produced interesting data for both families of
viruses. The matrices of both influenza and HIV viruses
are relatively disordered (see Tables 3 and 4). The HIV
matrix protein is predicted to be highly disordered,
whereas the influenza virus matrix protein is predicted to
be only moderately disordered (or somewhat ordered) by
PONDR® VLXT. This peculiarity may highlight an impor-
tant difference between the two families of viruses and
may have important medical implications. For the influ-
enza virus, the proteins that are even closer to the core
include NS1, NP and PB1. All these proteins are predicted
to be highly disordered.
More disorder at the core unless proteins are enzymes
While M1 is known to bind RNA, proteins that are located
closer to the core are even more likely to interact with the
viral RNA. This may account for the trend that, for pro-
teins that are closer to the core, the amount of predicted
disorder increases. This trend is clearly highlighted in Fig-
ure 2. Interestingly, a number of RNA-binding proteins
that are not viral have also been predicted to be disor-
dered (Table 6). This trend can also be seen for HIV virus
proteins, with the exception that enzymes are usually pre-
dicted to be ordered. Intergrases (IN), Reverse Tran-
scriptase (RT), and to some extent Protease (PR)
exemplify the observation that enzymes are exceptions to
the general trend. That is, all three of these proteins are
enzymes, and they are all predicted to be relatively
ordered. Reverse transcriptase and integrases, however,
are also RNA-binding proteins, with the RT having an
additional ability to bind DNA. In such cases, the proteins
Table 5: Predicted intrinsic disorder in surface proteins of influenza virus.
Disorder prediction in various NA subtypes
Protein Accessions %VLXT(VL3) Method
N1 2hu0.pdb, Subunit A 8 (0) X-Ray
N2 2f10.pdb, Subunit: A 25 (13) X-Ray
N4 2htw.pdb, Subunit A 4 (0) X-Ray
N6 2w20.pdb, Subunit: A 15 (27) X-Ray
N8 2htr.pdb, Subunit: A 4 (48) X-Ray
N9 1jsn.pdb, Subunit S 15 X-Ray
Disorder predictions in various HA subtypes
Protein Subunit Accessions %VLXT(VL3)
H1 HA1 1ruz.pdb, Subunit H 12 (0) X-Ray
HA2 1ruz.pdb, Subunit:I 12 (0)
H3 HA1 1mqn.pdb, Subunit: A 25 (0) X-Ray
HA2 1mqn.pdb, Subunit: B 19 (1)
H5 HA1 2ibx.pdb, Subunit: A 12 (2) X-RAY
HA2 2ibx.pdb Subunit: B 13 (0)
H7 HA1 1ti8.pdb, Subunit: A 22 (11) X-Ray
HA2 1ti8.Pdb, Subunit:: B 30 (0)BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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Chart summarizing the percentages of residues predicted to be disordered in HIV-1 (A) and the influenza A virus proteins (B) Figure 2
Chart summarizing the percentages of residues predicted to be disordered in HIV-1 (A) and the influenza A 
virus proteins (B). Top of each panel represents chart of proteins with percentages of residues that are predicted to be dis-
ordered by PONDR® VLXT. The types of proteins are also summarized. It should be noted that the percentages of predicted 
to be disordered residues of HA vary with subtypes, but HA is essentially predicted to be quite ordered. More information is 
available in Table 5.BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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typically have (nucleic binding) regions that are some-
what disordered and also (catalytic) regions that are
highly ordered respectively. Such trends have been
observed for non-viral proteins in general [24-26], and the
viral proteins seem to follow this rule of thumb as well.
Consistent with these trends, the HIV protease, which
binds neither RNA nor DNA, is not surprisingly predicted
to be the most ordered of all.
Predicted disorder in hemagglutinin might correlate with 
viral infectivity
Loss of infectivity for specific virus subtype via fatty acid deprivation
The attachment and membrane fusion of the influenza
virus and the host cell are mediated by its hemagglutinin
(HA). HA is a homotrimer, and each monomer comprises
an ectodomain with about 510 amino acid residues, a
transmembrane domain with 27 residues, and a cytoplas-
mic domain with 10 to 11 residues. The HA monomer is
synthesized as a single polypeptide chain and cleaved into
two subunits, HA1 and HA2, by proteolytic enzymes after
virus budding or during intracellular transport. The HA1
and HA2 subunits are functionally specialized. HA1 car-
ries receptor-binding activity, and HA2 mediates mem-
brane fusion [38]. As discussed briefly above, the amount
of intrinsic disorder in HA1 and HA2 varies with the viral
subtype (Table 5). Analysis of the past experimental data
in comparison with the disorder predictions in Table 5
suggests that variations in the infectivity of the virus [39],
variations in the assembly of the HA proteins, and varia-
tions in the correlation between protein-membrane inter-
action and the lipid raft motion may all be related to the
amount of predicted disorder. For example, one of the HA
functions is to assemble proteins, including those
involved into the formation of pores. Acetylation of the
HA molecules often affects this function, which is crucial
for the infectivity of the virus. However, it has been shown
that H1, H3, and H7 behave differently when the sites that
are normally palmitylated are mutated. Viral subtypes
with H1 proteins were most affected by the mutations,
whereas the virions did not lose much of their infectivity
in the case of H3 and H7 [40,41]. Table 5 shows that,
among the viral subtypes analyzed, H1 proteins possess
the least amount of predicted disorder, whereas H3 and
H7 proteins were predicted to be essentially more disor-
dered. We showed elsewhere that enzyme-mediated post-
translational modifications usually occur with disordered
regions [24-26,42]. The increased predictions of intrinsic
disorder in HA are associated with increased infectivity of
influenza virus, perhaps via changes in posttranslational
modification the ease of which may depend on the ten-
dency to be disordered.
Intrinsic disorder may provide a bypass to the lipid raft requirement
For all enveloped viruses, the envelope is derived from the
host cell during the process of virus budding. In the case
of influenza virus, budding takes place at the apical
plasma membrane and is heavily dependent on the pres-
ence of lipid microdomains, or "rafts" [43-45]. Lipid rafts,
also known as detergent-insoluble glycosphingolipid-
enriched domains, are specific domains on plasma mem-
branes that are enriched in detergent-insoluble glycolipids
(DIGs), cholesterol and sphingolipids [46-48]. Levels of
cholesterol and sphingolipids can vary amongst individu-
als, which alters the extent the raft formation. Lipid rafts
play an important role in several biological processes,
including signal transduction, T-cell activation, protein
sorting, and virus assembly and budding [48]. Such envel-
oped viruses incorporate some integral membrane pro-
teins; among the best studied are the influenza virus
hemagglutinin (HA) and neuraminidase (NA) [49].
Acetylation of the envelope proteins and also palmitoyla-
tion are important for these viral proteins to be targeted to
the lipid raft microdomains on the cell surface [50]. C-ter-
minal domains of both HA and NA of influenza virus are
crucial for association with rafts and this interaction con-
stitutes part of the signaling machinery necessary for api-
cal targeting in polarized cells. In fact, the cytoplasmic
tails of HA and NA are so important for assembly that the
information contained in these tails is partially redundant
[51]. For example, the removal of the cytoplasmic tail or
mutation of the three palmitoylated cysteine residues in
the transmembrane (TM) domain and the cytoplasmic
tail of influenza virus hemagglutinin (HA) was shown to
decrease the association of HA with lipid rafts, decrease
the incorporation of HA into virions [44], and modulates
incorporation of cholesterol into the viral envelope.
The level of the envelope cholesterol has been shown to
play a crucial role in the HA-mediated fusion of the influ-
enza virus with the host cell [52]. These data were
Table 6: Summary of protein types generally predicted to be ordered or disordered. Information is deduced from the literature data 
mainly reported in [23-26].
Protein Observed/Predicted Disorder
RNA Binding Proteins Highly Disordered
DNA Binding Protein Disordered
Enzymes (e.g. Proteases, Ribonucleases) Ordered
Non-Multiply Spanning Membrane Proteins Disordered
Transmembrane Proteins (e.g Pores) OrderedBMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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obtained for the WSN (H1N1) strain of influenza virus
and the authors proposed that differences may exist with
other virus strains. Perhaps the virion cholesterol is
important for the organization of influenza virus HA trim-
ers into fusion-competent domains, and perhaps also the
depletion of cholesterol inhibits virus infectivity due to
inefficient fusion [52]. Here we suggest that variations in
intrinsic disorder in the surface proteins may play similar
role. In fact, Table 5 shows that H1 is predicted to be
ordered, whereas H3 and H7 are predicted to be more dis-
ordered. This increased level of disorder might offer a
mechanism for proteins to by-pass the lipid raft require-
ment. Studies on chimera proteins with specific swapping
of regions predicted to be ordered or disordered could be
used to test this proposed mechanism.
Disorder or order pairing of HA and NA may be 
intertwined with the evolution of the influenza viruses
Ordered-ordered versus disordered-disordered HA and NA in 
influenza A virus serotypes
As has already been mentioned, sixteen HA serotypes and
nine NA subtypes of influenza A virus are known. Among
the three influenza types, the type A viruses are the most
virulent human pathogens that cause the most severe dis-
ease. The list of some influenza A virus serotypes with the
largest known human pandemic deaths includes H1N1
("Spanish flue"), H2N2 ("Asian flue"), H3N2 ("Hong
Kong flu"), and H5N1 ("Avian flue"). Table 7 illustrates
an interesting correlation between the amounts of pre-
dicted intrinsic disorder in HA and NA proteins from the
different influenza A virus serotypes: in H1N1 and H5N1
subtypes, both HA and NA are predicted to be ordered,
whereas H3N2 serotype is characterized by more disor-
dered hemagglutinin and neuraminidase. Perhaps such a
combination is not coincidental but is instead evolution-
arily preferred.
Disorder as a viral weapon for evading the immune 
response
An understanding of viral surface proteins is crucial for
developing the appropriate vaccination strategies and for
improving the understanding of the immune responses.
The comparative analysis of intrinsic disorder distribution
in the HIV and influenza virions uncovers specific pat-
terns that could provide some useful insight into these
problems. Above we showed that the level of predicted
disorder varies in the HA and NA subtypes. This observa-
tion might be used for tuning vaccination strategies. How-
ever, the data in Table 5 shows that the variations in the
predicted disorder do not deviate greatly. Furthermore, in
general, HA and NA can be described as highly ordered to
or moderately disordered (see Tables 3 and 5, and Figure
2). This may account for the observations that the anti-
influenza antibodies recognize and bind various HA and
NA subtypes providing the grounds for the development
of an effective immune response and therefore for the
elaboration of the appropriate vaccination strategies. The
situation with immunogeneity of HIV virus is totally dif-
ferent. Although antibodies were found to bind to several
HIV proteins, these HIV-binding antibodies do not lead to
an effective immune response. The reason for this is
unknown as of yet. However, we believe that a compara-
tive analysis of disorder distribution in proteins from
both orthomyxoviruses and lentiviruses might potentially
provide greater insight into this problem.
The first step in HIV infection is the binding of the enve-
lope glycoprotein gp120 to the host cell receptor CD4
[53,54]. CD4 binding induces extensive structural rear-
rangements in gp120, resulting in the exposure of a bind-
ing surface for the second host cell chemokine receptor,
CCR5 or CXCR4 [55,56]. The interface between gp120
and CD4 is highly conserved among different HIV-1 iso-
lates [57]. In gp120-CD4 complexes, CD4 was shown to
interact with all three domains of gp120, including the
inner domain, the outer domain, and the bridging β-
sheet. Furthermore, in all structures of various gp120-CD4
complexes analyzed by X-ray crystallography, a deep
hydrophobic cavity enclosed by conserved gp120 residues
was detected [58]. CD4 residue Phe43 is the only cavity-
interacting residue in CD4. It fits to the opening of this
cavity [57] and was shown to contribute about 23% of the
total interaction surface [58]. According to our analysis,
the surface protein of the HIV virion, gp120, has a consist-
ently low predicted disorder value across various strains of
lentiviruses (data not shown). Therefore, this feature has
functional implications since a rigid structure of gp120
might be necessary for the formation of a stable complex
with the host protein, CD4.
Table 7: Observed paring of predicted disorder of HA-NA in subtypes involved in major epidemics. Quantitative details of the 
respective predicted disorder values can be found in Table 5.
Subtype Description HA (Predicted Disorder/Order) NA (Predicted Disorder/Order)
H1N1 "Spanish Flu" (1918) Ordered Ordered
H2N2 "Asian Flu" (1957) NAa More Disordered
H3N2 "Hong Kong Flu" (1968) More Disordered More Disordered
H5N1 "Avian Flu" (1997) Ordered Ordered
aPDB structure of H2 has not been found, presumably, because the H2N2 subtype evolved quickly into H3N2.BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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The analysis of Figure 2 reveals that, unlike the proteins of
influenza A virus, HIV proteins do not follow the trend of
having increasing amount of predicted disorder as the
locations of the proteins become closer to the core. In
part, this distinct trend can be attributed to the presence
of several enzymes in the HIV virion capsule. However,
even the HIV matrix proteins and some of the surface pro-
teins have quite high percentages of residues predicted to
be disordered. For example, Tables 3 and 4 shows that the
matrix protein of influenza virus (M1) is predicted to be
only somewhat disordered (25% by PONDR® VLXT and
0% by PONDR® VL3), whereas the matrix protein of HIV,
MA (p17), has a very high percentage of disordered resi-
dues (61% PONDR® VLXT and 48% by PONDR® VL3).
Furthermore, Table 3 shows also that this very high abun-
dance of intrinsic disorder is extended to areas above the
matrix and is observed in the HIV envelope. The gp41
(TM), which is a transmembrane protein involved in
fusion, has a high predicted disorder rate, in striking con-
trast to the fusion protein of the influenza virus (HA2,
Table 5).
An interesting possibility is that the high prevalence of
intrinsic disorder in proteins located in the close proxim-
ity to the surface of HIV- related viruses provides a mech-
anism for the avoiding the induction of immune
response. In fact, the antigenicity of a given protein is
known to reside in a restricted number of antigenic deter-
minants (sites or epitopes) located on its surface. As anti-
genic determinants of several proteins have been shown
to correspond to the surface regions with high segmental
mobility (high B-factor values), the high mobility of an
antigenic determinant was suggested to help in the deter-
minant adjustment to a pre-existing antibody site not
fashioned to fit the exact geometry of a protein [59]. On
the other hand, additional research has revealed that an
effective antigenic site, being mobile, should possess an
internal propensity to form ordered structure; i.e., it
should not be completely disordered. Importantly, some
long disordered regions and intrinsically disordered pro-
teins promote weak immune responses or are even com-
pletely non-immunogenic [60-62]. This is further
illustrated by the analysis of literature data on the gp120
immunogeneity.
Neutralizing antibodies play a significant role in the vac-
cines development. The key HIV targets for neutralizing
antibody are found in the external envelope protein,
gp120 [63-65]. The principle neutralizing determinant of
HIV-1 virus was mapped to the third variable (V3) loop
region (residues 301–341) of gp120 [66-68]. This V3 loop
is also required for viral entry into target T cells and mac-
rophages [69] and interacts with chemokine co-receptors
on the surfaces of these cells [55,56,70]. The V3 loop is
characterized by a highly variable amino acid sequence,
which is assumed to contribute to the ability of HIV to
escape the host immune response [71].
Using solid state NMR spectroscopy it has been shown
that a 24-residue fragment of the V3 loop of HIV-1 strain
III (namely residues 308–331) that includes the GPGR
motif is conformationally heterogeneous [71]. Further-
more, this fragment was shown to adopt very different
conformations when bound to different anti-V3 antibod-
ies [71-73]. The disorder-to-order transition of V3 loop
has been hypothesized to play a crucial role in function of
this protein, determining its potential to interact with a
variety of chemokine receptors and thus allowing differ-
ent avenues into the cell [71]. The same mechanism
makes devising vaccines against HIV very difficult because
some V3 loops escape detection by antibodies that specif-
ically recognize a particular conformation but that fail to
bind other conformations. These observations provide
further support to the hypothesis that high abundance of
intrinsic disorder in proteins located in the close proxim-
ity to the surface of HIV-1 can help this virus to avoid the
immune response induction. Therefore, intrinsic disorder
might represent a crucial viral weapon for evading
immune response.
We previously discussed several pathogens that use disor-
dered regions for binding, with these disordered regions
being weakly immunogenic, and suggested using disorder
for binding might be a common strategy for avoiding the
immune system [60]. For this mechanism, the disordered
region needs to have a sufficiently high flexibility. For
such flexible disordered regions, we speculate that the rel-
atively small size of the antibody binding site provides
insufficient binding energy to fold the flexible disorder
and therefore cannot bind tightly enough for the genera-
tion of an immune response. On the other hand, in our
proposal the relatively larger size of the receptor binding
surface can provide sufficient energy of association to
overcome the flexibility and thereby induce binding via a
disorder-to-order transition. The flexibility of the key HIV
proteins may be slightly less than that for the previously
discussed pathogens, and so antibodies are produced and
these bind to different conformational states. Yet the abil-
ity of the flexible disordered binding region to fold in dif-
ferent ways may lead to confusion of the immune system
and may substantially weaken the overall immune
response as discussed above. Thus, antigenic sites may
benefit by being somewhat flexible [59], but probably
become less effective as the flexibility increases beyond
some useful level.
Conclusion
Results presented in this paper show the usefulness of the
intrinsic disorder prediction for the comparative analysis
of viral proteins. This approach offers several advantages,BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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including the opportunity to map proteins by functional-
ity, predicted disorder, and locality across viral species,
strains and subtypes. Furthermore, it provides useful
benchmarks for the evaluation of the intrinsic disorder
concept and for the analysis of various disorder predic-
tors. Using this comparative study of predicted disorder,
several interesting patterns in the behaviour of viral pro-
teins from HIV-1 and influenza A viruses were uncovered.
We have shown that the patterns of predicted disorder can
be mapped and related to the functions of the various pro-
teins. There is evidence that the functions and the amount
of disorder of the proteins are related to their physical
location in the virion. Some of the key findings of this
paper are further outlined below.
Intrinsic disorder is unevenly distributed within the viri-
ons, especially for influenza, with the least predicted dis-
order being observed at the surface proteins and the most
disorder being characteristic for the proteins at the virion
core. While a similar trend is observed for HIV, the disor-
der changes are much less pronounced.
Proteins near the surface of HIV-related viruses are charac-
terized by higher levels of predicted disorder as compared
to influenza. Although the major surface protein, gp120,
has been consistently predicted to be ordered, its major
neutralizing determinant is highly mobile. These data
support a scenario where HIV virions can escape immune
response despite the availability of antibodies for the HIV-
related proteins.
Significant variations in the amount of predicted disorder
by HA subtypes in influenza A virus were observed. This
might provide an explanation for the variations in the
functionality and infectivity of specific viral subtypes. Fur-
thermore, NA and HA of major influenza A pandemic,
tend to pair in such a way that both tend to be predicted
either ordered-ordered or disordered-disordered. Such
behaviour might be linked to the evolutionary advantages
of being ordered or disordered, but more experiments are
needed to test this conjecture.
Methods
Tools and materials used
The programs were written in C#, JAVA®-JDBC, Microsoft®
SQLSERVER, and MYSQL. Object-oriented programming
in JAVA®-5 was also used. The design of the database was
done using relational database concepts with normaliza-
tion in Third Normal Form Boyce-Codd Normal Form
[74].
PONDR® VLXT and VL3 predictors
The predictors of intrinsic disorder used in this paper are
PONDR® VLXT and VL3 [18,19,21]. PONDR® VLXT was
built using 15 proteins whose structures were elucidated
using X-ray diffraction, NMR spectroscopy, circular dichr-
oism spectroscopy, or limited proteolysis [19]. PONDR®
VL3, on the other hand, was built using a combination of
30 neural networks and a training set of disordered
regions of 150 proteins [21].
Relational database and entity relationship diagram
In order to do a comparative study of the viral proteins, it
was necessary to develop a database that would capture
the information from the amino acid sequence and the
disorder prediction. The list of proteins of interest
included viral proteins of lentiviruses and orthomyxovi-
ruses. Searches were done on the list using the Entrez web-
site [22]. Available samples were randomly chosen with
preferences given to those with longer chains and those
with binding partners. Whenever possible, corresponding
viral protein of different virus strains were included as
samples and annotated. The respective FASTA and PDB
[22] files were downloaded and stored using a JAVA® pro-
gram and the list prepared.
In order to provide a benchmark for predicted disorder, a
set of proteins from PDB-Select 90 was randomly chosen
and downloaded to the database. The mean and standard
deviation were calculated using bootstrapping techniques
when necessary [75]. PDB Select90 [23] is defined as a
representative, non-redundant subset of the PDB [22],
made up of proteins that have no more than 95%
sequence identity [23].
Figure 3 shows the Entity-Relationship (ER) Diagram
[76]. The ER Diagram attempts to summarize the relation-
ships among entities in a relational database. In our case,
entity Virus_Type contains information about the virus
family (such as Lentiviradae), while entity Viruses con-
tains names of viruses such as HIV-1 on the virus_id
attribute. In order to query by protein types, the entities
protein_category and protein_type were designed.
Attributes for protein category includes accession_code
and protein_cat_desc, which include descriptions of pro-
teins such as p17. Protein_type_id links the
Protein_category entity to the Protein_Type entity, which
contains information relayed to protein type, e.g. matrix
protein.
Using a set of programs written in JAVA®, the PDB and
FASTA files were searched, and the essential information
was placed in the MYSQL tables using accessions
seq_access and seq_access_atom. The necessary FASTA
files were then used to generate PONDR®  VLXT and
PONDR®  VL3 scores via a LINUX BASH shell script.
Another JAVA® program was then used to load the predic-
tion into the seq_predn table. Information regarding to
the virus and its subtype was initially stored in a Micro-BMC Genomics 2008, 9(Suppl 2):S4 http://www.biomedcentral.com/1471-2164/9/S2/S4
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An entity-relationship (ER) diagram of the viral protein database Figure 3
An entity-relationship (ER) diagram of the viral protein database. Each entity contains attributes. The type of rela-
tionships is shown by the connector and/or the black circle. For example, a black circle followed by dotted line indicates a 
many to zero or one relationship. Whereas, the black circle followed by a solid line indicates a many to one relationship [76].
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soft® SQLSERVER database via C# and later was trans-
ferred to the MySQL database server.
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